BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 1451245)

  • 21. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease.
    deFilippi CR; Willett DL; Irani WN; Eichhorn EJ; Velasco CE; Grayburn PA
    Circulation; 1995 Nov; 92(10):2863-8. PubMed ID: 7586253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hibernation and myocardial ischemia: clinical detection by positron emission tomography.
    Uren NG; Camici PG
    Cardiovasc Drugs Ther; 1992 Jun; 6(3):273-9. PubMed ID: 1637733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization.
    vom Dahl J; Eitzman DT; al-Aouar ZR; Kanter HL; Hicks RJ; Deeb GM; Kirsh MM; Schwaiger M
    Circulation; 1994 Nov; 90(5):2356-66. PubMed ID: 7955194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium.
    Sun KT; Czernin J; Krivokapich J; Lau YK; Böttcher M; Maurer G; Phelps ME; Schelbert HR
    Circulation; 1996 Dec; 94(12):3146-54. PubMed ID: 8989122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time dependence of residual tissue viability after myocardial infarction assessed by [18F]fluorodeoxyglucose and positron emission tomography.
    Fragasso G; Chierchia SL; Lucignani G; Landoni C; Conversano A; Gilardi MC; Colombo F; Rossetti C; Fazio F
    Am J Cardiol; 1993 Dec; 72(19):131G-139G. PubMed ID: 8279350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histochemical correlates of (15)O-water-perfusable tissue fraction in experimental canine studies of old myocardial infarction.
    Iida H; Tamura Y; Kitamura K; Bloomfield PM; Eberl S; Ono Y
    J Nucl Med; 2000 Oct; 41(10):1737-45. PubMed ID: 11038006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism.
    Gropler RJ; Geltman EM; Sampathkumaran K; Pérez JE; Moerlein SM; Sobel BE; Bergmann SR; Siegel BA
    J Am Coll Cardiol; 1992 Sep; 20(3):569-77. PubMed ID: 1512335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of functional recovery after revascularization in patients with chronic ischemic myocardial dysfunction: perfusable tissue index by positron emission tomography and contrast-enhanced MRI comparison study.
    Bondarenko O; Knaapen P; Beek AM; Boellaard R; Lammertsma AA; van Rossum AC
    Nucl Med Commun; 2011 Dec; 32(12):1169-73. PubMed ID: 22045477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability.
    Gerber BL; Ordoubadi FF; Wijns W; Vanoverschelde JL; Knuuti MJ; Janier M; Melon P; Blanksma PK; Bol A; Bax JJ; Melin JA; Camici PG
    Eur Heart J; 2001 Sep; 22(18):1691-701. PubMed ID: 11511119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization.
    Marinho NV; Keogh BE; Costa DC; Lammerstma AA; Ell PJ; Camici PG
    Circulation; 1996 Feb; 93(4):737-44. PubMed ID: 8641003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Course of impaired left ventricular function after acute myocardial infarction predicted with planar thallium-201 chloride and F18-fluorodeoxyglucose imaging.
    Huitink JM; Visser FC; Bax JJ; van Lingen A; Visser CA
    Int J Cardiol; 1996 Dec; 57(3):271-81. PubMed ID: 9024916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
    Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
    J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty acid uptake is preserved in chronically dysfunctional but viable myocardium.
    Mäki MT; Haaparanta MT; Luotolahti MS; Nuutila P; Voipio-Pulkki LM; Bergman JR; Solin OH; Knuuti JM
    Am J Physiol; 1997 Nov; 273(5):H2473-80. PubMed ID: 9374787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium.
    Vanoverschelde JL; Wijns W; Depré C; Essamri B; Heyndrickx GR; Borgers M; Bol A; Melin JA
    Circulation; 1993 May; 87(5):1513-23. PubMed ID: 8491006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography.
    Rechavia E; de Silva R; Kushwaha SS; Rhodes CG; Araujo LI; Jones T; Maseri A; Yacoub MH
    J Am Coll Cardiol; 1997 Aug; 30(2):533-8. PubMed ID: 9247529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
    Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo assessment of myocardial viability after acute myocardial infarction: A head-to-head comparison of the perfusable tissue index by PET and delayed contrast-enhanced CMR.
    Timmer SAJ; Teunissen PFA; Danad I; Robbers LFHJ; Raijmakers PGHM; Nijveldt R; van Rossum AC; Lammertsma AA; van Royen N; Knaapen P
    J Nucl Cardiol; 2017 Apr; 24(2):657-667. PubMed ID: 26843199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Usefulness of 18F-fluorodeoxyglucose positron emission tomography for evaluating myocardial viability in old myocardial infarction].
    Niwayama H; Yoshida K; Masuda Y; Inagaki Y
    Kaku Igaku; 1992 Nov; 29(11):1341-52. PubMed ID: 1484426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can nitrogen-13 ammonia kinetic modeling define myocardial viability independent of fluorine-18 fluorodeoxyglucose?
    Beanlands RS; deKemp R; Scheffel A; Nahmias C; Garnett ES; Coates G; Johansen HL; Fallen E
    J Am Coll Cardiol; 1997 Mar; 29(3):537-43. PubMed ID: 9060890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of assessing regional myocardial uptake of 18F-fluorodeoxyglucose using single photon emission computed tomography.
    Bax JJ; Visser FC; van Lingen A; Huitink JM; Kamp O; van Leeuwen GR; Visser GW; Teule GJ; Visser CA
    Eur Heart J; 1993 Dec; 14(12):1675-82. PubMed ID: 8131767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.